E

ENVB

Enveric Biosciences Inc

1.13

-0.13-10.32%
After Hours: 1.140  +0.010  +0.89%19:59 08/29 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.250/1.260
TODAY RANGE1.130-1.260
VOL488.24K
MARKET CAP3.67M
52 WEEK RANGE1.010-8.40
AVG VOL (3M)216.55K
% TURNOVER15.04%
TURNOVER--
P/E (TTM)-0.1068
% RANGE10.32%
EPS(TTM)-10.5767
P/E(FORWARD)-1.3140
P/B1.565
BVPS0.7220
DIVIDEND--
P/S0.0005
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.54M
SHARES OUTSTANDING3.25M
NEXT EARNINGS11/12-11/17
FREE FLOAT2.25M
LOT SIZE1
EX-DATE01/29/2025
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

E

Enveric Biosciences Inc

ENVB

-10.32%
1.13

R

Regeneron Pharmaceuticals

REGN

+0.19%
580.70

E

Entero Therapeutics

ENTO

+5.81%
2.28

B

BIONTECH

BNTX

-1.89%
100.00

U

United Therapeutics Corp.

UTHR

-0.81%
304.76

V

Vertex Pharmaceuticals Inc

VRTX

-0.26%
391.02

S

Siga Technologie

SIGA

+2.19%
8.39

M

Moderna

MRNA

-1.55%
24.09

C

Charles Riv Labs Intl Inc

CRL

+0.06%
163.31

M

Medpace Holdings

MEDP

+0.54%
475.51

T

Talphera Inc

TLPH

-0.86%
0.5410

I

ICON PLC

ICLR

+1.65%
177.94

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

+1.10%
190.81

M

MOLECULAR PARTNERS AG

MOLN

+4.16%
3.75

G

Gilead Sciences Inc

GILD

+0.36%
112.97

A

Arcturus Therape

ARCT

-1.68%
17.01

P

PRA Health

PRAH

--
165.21

I

Incyte Corp

INCY

+1.09%
84.61

A

Aptevo Therapeutics Inc

APVO

-3.53%
1.64

B

Biospecifics

BSTC

+0.15%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.